Comparison of the immunomodulatory effects of L. donovani and L. major excreted-secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cells

Vaccine

Volumn 26, Issue 48, 2008, Pages 6119-6123

  Revest, Matthieu ^a   Donaghy, Ludovic ^a   Cabillic, Florian ^a   Guiguen, Claude ^a   Gangneux, Jean Pierre ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Dendritic cells; Excreted secreted antigens; Leishmania

Indexed keywords

CD209 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; EXCRETED SECRETED ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; LEISHMANIA DONOVANI ANTIGEN; LEISHMANIA MAJOR ANTIGEN; MEMBRANE ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL MODEL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHENOTYPING; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; NONHUMAN; PARASITE VIABILITY; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIGENS, CD40; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; LEISHMANIA DONOVANI; LEISHMANIA MAJOR;

EID: 55249100480     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.005     Document Type: Article

References (32)

1. Blackwell J.M. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112 Suppl. (1996) S67-S74
2. Gangneux J.P., Sulahian A., Honore S., Meneceur P., Derouin F., and Garin Y.J. Evidence for determining parasitic factors in addition to host genetics and immune status in the outcome of murine Leishmania infantum visceral leishmaniasis. Parasite Immunol 22 10 (2000) 515-519
3. Guler M.L., Gorham J.D., Hsieh C.S., Mackey A.J., Steen R.G., Dietrich W.F., et al. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271 5251 (1996) 984-987 16
4. Antoine J.C., Prina E., Courret N., and Lang T. Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts. Adv Parasitol 58 (2004) 1-68
5. Scott P., and Hunter C.A. Dendritic cells and immunity to leishmaniasis and toxoplasmosis. Curr Opin Immunol 14 4 (2002) 466-470
6. Brandonisio O., Spinelli R., and Pepe M. Dendritic cells in Leishmania infection. Microb Infect 6 15 (2004) 1402-1409
7. McDowell M.A., Marovich M., Lira R., Braun M., and Sacks D. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun 70 8 (2002) 3994-4001
8. Colmenares M., Corbi A.L., Turco S.J., and Rivas L. The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of Leishmania. J Immunol 172 2 (2004) 1186-1190
9. von Stebut E., Belkaid Y., Jakob T., Sacks D.L., and Udey M.C. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 188 8 (1998) 1547-1552
10. Moll H., Scharner A., and Kampgen E. Increased interleukin 4 (IL-4) receptor expression and IL-4-induced decrease in IL-12 production by Langerhans cells infected with Leishmania major. Infect Immun 70 3 (2002) 1627-1630
11. Konecny P., Stagg A.J., Jebbari H., English N., Davidson R.N., and Knight S.C. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur J Immunol 29 6 (1999) 1803-1811
12. Amprey J.L., Spath G.F., and Porcelli S.A. Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani. Infect Immun 72 1 (2004) 589-592
13. Ghosh M., and Bandyopadhyay S. Interaction of Leishmania parasites with dendritic cells and its functional consequences. Immunobiology 209 1-2 (2004) 173-177
14. Quinones M., Ahuja S.K., Melby P.C., Pate L., Reddick R.L., and Ahuja S.S. Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J Exp Med 192 4 (2000) 507-516
15. Prina E., Abdi S.Z., Lebastard M., Perret E., Winter N., and Antoine J.C. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J Cell Sci 117 Pt 2 (2004) 315-325
16. Bennett C.L., Misslitz A., Colledge L., Aebischer T., and Blackburn C.C. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur J Immunol 31 3 (2001) 876-883
17. Coler R.N., and Reed S.G. Second-generation vaccines against leishmaniasis. Trends Parasitol 21 5 (2005) 244-249
18. Breton M., Tremblay M.J., Ouellette M., and Papadopoulou B. Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis. Infect Immun 73 10 (2005) 6372-6382
19. Jean-Moreno V., Rojas R., Goyeneche D., Coombs G.H., and Walker J. Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp Parasitol 112 1 (2006) 21-30
20. Stober C.B., Lange U.G., Roberts M.T., Gilmartin B., Francis R., Almeida R., et al. From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection. Vaccine 24 14 (2006) 2602-2616
21. Saraiva E.M., de Figueiredo Barbosa A., Santos F.N., Borja-Cabrera G.P., Nico D., Souza L.O., et al. The FML-vaccine (Leishmune) against canine visceral leishmaniasis-a transmission blocking vaccine. Vaccine 24 13 (2006) 2423-2431
22. Garg R., and Dube A. Animal models for vaccine studies for visceral leishmaniasis. Indian J Med Res 123 3 (2006) 439-454
23. Telino E., De Luca P.M., Matos D.C., Azeredo-Coutinho R.B., Meirelles M.N., Conceicao-Silva F., et al. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin Exp Immunol 143 2 (2006) 338-344
24. Rosa R., Rodrigues O.R., Marques C., and Santos-Gomes G.M. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response. Exp Parasitol 109 2 (2005) 106-114
25. Kedzierski L., Zhu Y., and Handman E. Leishmania vaccines: progress and problems. Parasitology 133 Suppl. (2006) S87-S112
26. Lemesre J.L., Holzmuller P., Cavaleyra M., Goncalves R.B., Hottin G., and Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 22 (2005) 2825-2840
27. Holzmuller P., Cavaleyra M., Moreaux J., Kovacic R., Vincendeau P., Papierok G., et al. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis. Vet Immunol Immunopathol 106 3-4 (2005) 247-257
28. Woelbing F., Kostka S.L., Moelle K., Belkaid Y., Sunderkoetter C., Verbeek S., et al. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med 203 1 (2006) 177-188
29. Steigerwald M., and Moll H. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity. Infect Immun 73 4 (2005) 2564-2567
30. Jebbari H., Stagg A.J., Davidson R.N., and Knight S.C. Leishmania major promastigotes inhibit dendritic cell motility in vitro. Infect Immun 70 2 (2002) 1023-1026
31. Marovich M.A., McDowell M.A., Thomas E.K., and Nutman T.B. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol 164 11 (2000) 5858-5865
32. Maroof A., and Kaye P.M. Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection. Infect Immun 76 1 (2008) 239-249